SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001999371-24-001730
Filing Date
2024-02-08
Accepted
2024-02-08 20:27:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SC 13G nnb-sc13ga_123123.htm SC 13G/A 41453
2 ITEM 7 INFORMATION ex99-a.htm EX-99.(A) 2202
3 CERTIFICATE OF INCUMBENCY ex99-b.htm EX-99.(B) 4115
  Complete submission text file 0001999371-24-001730.txt   49302
Mailing Address P.O. BOX 23224 DOHA S3 QATAR
Business Address OOREDOO TOWER (BUILDING 14), AL DAFNA ST (STREET 801) DOHA S3 QATAR 974 441 4466
Qatar Investment Authority (Filed by) CIK: 0001441449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: S3 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Subject) CIK: 0001760854 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91935 | Film No.: 24610868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)